MedPath

海南制药厂有限公司制药一厂

Ownership
-
Established
2002-06-11
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

128

NMPA:128

Drug Approvals

Compound Aminopyrine Phenacetin Tablets

Product Name
去痛片
Approval Number
国药准字H41020733
Approval Date
Mar 25, 2025
NMPA

Pyrantel Pamoate Tablets

Product Name
双羟萘酸噻嘧啶片
Approval Number
国药准字H41021020
Approval Date
Mar 24, 2025
NMPA

Phenprobamate Tablets

Product Name
苯丙氨酯片
Approval Number
国药准字H41020717
Approval Date
Mar 24, 2025
NMPA

Osalmid Tablets

Product Name
柳胺酚片
Approval Number
国药准字H41020747
Approval Date
Mar 24, 2025
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20093988
Approval Date
Jan 23, 2024
NMPA

Domperidone Tablets

Product Name
多潘立酮片
Approval Number
国药准字H20094059
Approval Date
Jan 23, 2024
NMPA

Isoniazid Tablets

Product Name
异烟肼片
Approval Number
国药准字H41023264
Approval Date
Jul 23, 2020
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H41020750
Approval Date
Jul 23, 2020
NMPA

Yansuan Zuoxuanmizuo Pian

Product Name
盐酸左旋咪唑片
Approval Number
国药准字H41020730
Approval Date
Jul 23, 2020
NMPA

Alprazolam Tablets

Product Name
阿普唑仑片
Approval Number
国药准字H41020741
Approval Date
Jul 23, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.